Venous Vascular Closure
0
Pipeline Programs
1
Companies
2
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
1 companies ranked by most advanced pipeline stage
CordisFL - Miami Lakes
2 programsMYNX CONTROLTM VENOUS Vascular Closure DeviceN/A1 trial
MYNX CONTROL™ Venous Vascular Closure Device 6F-12FN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2022
2023
2024
2025
2026
CordisMYNX CONTROLTM VENOUS Vascular Closure Device
CordisMYNX CONTROL™ Venous Vascular Closure Device 6F-12F
Clinical Trials (2)
Total enrollment: 691 patients across 2 trials
Mobilization and Outcomes After Venous Closure
Start: Nov 2025Est. completion: Aug 2026339 patients
N/AActive Not Recruiting
Evaluation of Safety and Efficacy of the Mynx Control Venous Vascular Closure Device 6F-12F vs Manual Compression
Start: Aug 2022Est. completion: Jul 2023352 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.